Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Literature
1.
Nordlund ML, Sugar A, Moroi SE (2000) Phacoemulsification and intraocular lens placement in eyes with cataract and congenital coloboma: visual acuity and complications. J Cataract Refract Surg 26:1035–1040PubMedCrossRef
2.
Duke-Elder WS (1963) System of ophthalmology, vol 3, part 2. Mosby, St Louis, pp 456–487
3.
Mann I (1957) Developmental abnormalities of the eye. Lippincott, Philadelphia, pp 68–94
4.
5.
Chaurasia S, Ramappa M, Sangwan VS (2012) Cataract surgery in eyes with congenital iridolenticular choroidal coloboma. Br J Ophthalmol 96:138–140PubMedCrossRef
Metadata
Title
Outcomes of phacoemulsification in eyes with congenital choroidal coloboma
Authors
Sudarshan Khokhar
Shikha Gupta
Rakhi Kusumesh
Gaurav Kumar
Publication date
01-10-2013
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 10/2013
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-013-2397-1

Other articles of this Issue 10/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2013 Go to the issue

Letter to the Editor

Nemorosone and its emerging anti-neoplastic effects

Neurophthalmology

Correlation of optical coherence tomography parameters with clinical and radiological progression in patients with symptomatic optic pathway gliomas

Medical Ophthalmology

Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma—results from a prospective interventional case series

Basic Science

mTOR regulates TGF-β2-induced epithelial–mesenchymal transition in cultured human lens epithelial cells

Basic Science

Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells

Ophthalmology

Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy